Marex Group’s Organon & Co OGN Stock Holding History

Marex Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31,200	Closed	-$587K	–	698
2024 Q1	$587K	Hold	31,200	–	–	0.02%	232
2023 Q4	$450K	Buy	+31,200	New	+$424K	0.02%	322

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group's OGN Position: Q2 2024 in Review

Marex Group sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 31,200 shares — an estimated $587K sold.

Marex Group first reported a position in OGN in Q4 2023 and held it in 2 quarters. The position peaked at $587K in Q1 2024. 725 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

Marex Group reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
Marex Group sold 31,200 Organon & Co shares in Q2 2024, an estimated $587K.
Marex Group first reported a position in Organon & Co in Q4 2023 and held it in 2 quarters.
Marex Group's Organon & Co position peaked at $587K in Q1 2024.
725 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Marex Group's 13F filing for Q2 2024, filed 2 Apr 2026.